five

Available IPD datapackage for study 'Phase 1: A Single-Center, Randomized, Blinded, Placebo-Controlled, Single-Administration, Sequential-Cohort, Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants'

收藏
DataCite Commons2025-07-07 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/dataPackages/PR00007176.0
下载链接
链接失效反馈
官方服务:
资源简介:
The primary objective of the study is to determine the safety/tolerability profile, systemic PK behavior, and immunogenicity of single IV and SC administrations of BG00010 to sciatica participants.
提供机构:
Vivli
创建时间:
2025-07-07
二维码
社区交流群
二维码
科研交流群
商业服务